GlassScriptPhysician profile
Raynelle Nash
NPI 1184349037
$2,784.96
in general payments reported to CMS, 2019-2025
9 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $23.86 · 2023: $785 · 2024: $604 · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,250 · Travel and Lodging: $1,088 · Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,250.00 |
| Travel and Lodging | $1,088.34 |
| Food and Beverage | $422.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Moximed, INC | $1,280.98 | 2025 | Misha Knee System, Small, Left |
| Pacira Pharmaceuticals Incorporated | $526.71 | 2024 | Iovera, Zilretta, Exparel |
| Mission Medical Distribution, LLC | $500.61 | 2023 | |
| Arthrex, INC. | $186.40 | 2023 | |
| Depuy Synthes Sales INC. | $144.10 | 2023-2025 | Inhance, Dynacord, Truespan Orthocord |
| Vertex Pharmaceuticals Incorporated | $59.26 | 2024-2025 | |
| Bioventus LLC | $38.96 | 2025 | Xcell |
| Anika Therapeutics, INC. | $24.08 | 2024 | Tactoset, X-Twist, Integrity |
| Medacta USA, INC. | $23.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raynelle Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.